AquaBounty Technologies, Inc. (AQB)
1.28
-0.05
(-3.76%)
USD |
NASDAQ |
Aug 26, 16:00
1.28
0.00 (0.00%)
After-Hours: 20:00
AquaBounty Technologies Enterprise Value : 4.960M for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 4.960M |
| August 24, 2026 | 4.857M |
| August 21, 2026 | 4.857M |
| August 20, 2026 | 4.857M |
| August 19, 2026 | 4.960M |
| August 18, 2026 | 5.218M |
| August 17, 2026 | 5.320M |
| August 14, 2026 | 5.758M |
| August 13, 2026 | 5.835M |
| August 12, 2026 | 5.218M |
| August 11, 2026 | 5.784M |
| August 10, 2026 | 5.166M |
| August 07, 2026 | 4.137M |
| August 06, 2026 | 3.622M |
| August 05, 2026 | 3.210M |
| August 04, 2026 | 2.798M |
| August 03, 2026 | 2.848M |
| July 31, 2026 | 2.776M |
| July 30, 2026 | 2.798M |
| July 29, 2026 | 2.847M |
| July 28, 2026 | 2.850M |
| July 27, 2026 | 2.747M |
| July 24, 2026 | 2.798M |
| July 23, 2026 | 2.958M |
| July 22, 2026 | 2.978M |
| Date | Value |
|---|---|
| July 21, 2026 | 3.056M |
| July 20, 2026 | 2.991M |
| July 17, 2026 | 3.107M |
| July 16, 2026 | 3.107M |
| July 15, 2026 | 3.210M |
| July 14, 2026 | 3.056M |
| July 13, 2026 | 3.216M |
| July 10, 2026 | 3.159M |
| July 09, 2026 | 2.828M |
| July 08, 2026 | 2.953M |
| July 07, 2026 | 3.106M |
| July 06, 2026 | 3.364M |
| July 02, 2026 | 3.416M |
| July 01, 2026 | 3.622M |
| June 30, 2026 | 3.622M |
| June 29, 2026 | 8.971M |
| June 26, 2026 | 9.023M |
| June 25, 2026 | 8.920M |
| June 24, 2026 | 9.435M |
| June 23, 2026 | 8.611M |
| June 22, 2026 | 8.560M |
| June 18, 2026 | 8.199M |
| June 17, 2026 | 8.611M |
| June 16, 2026 | 8.611M |
| June 15, 2026 | 8.714M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.379B |
| Agenus, Inc. | 620.93M |
| Alnylam Pharmaceuticals, Inc. | 31.79B |
| Amgen, Inc. | 282.39B |
| Anika Therapeutics, Inc. | 273.23M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.332M |
| Total Expenses (Quarterly) | 1.332M |
| EPS Diluted (Quarterly) | -0.3169 |
| Earnings Yield | -358.0% |
| Normalized Earnings Yield | -375.14 |